NDC 69379-010

Permavan External Patch

Permavan External Patch

Permavan External Patch is a Topical Patch in the Human Prescription Drug category. It is labeled and distributed by Home Aide Diagnostics, Inc.. The primary component is Trolamine Salicylate; Lidocaine; Dextromethorphan Hydrobromide.

Product ID69379-010_10dfa403-1c1a-6374-e054-00144ff8d46c
NDC69379-010
Product TypeHuman Prescription Drug
Proprietary NamePermavan External Patch
Generic NamePermavan External Patch
Dosage FormPatch
Route of AdministrationTOPICAL
Marketing Start Date2015-03-09
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameHome Aide Diagnostics, Inc.
Substance NameTROLAMINE SALICYLATE; LIDOCAINE; DEXTROMETHORPHAN HYDROBROMIDE
Active Ingredient Strength10 g/100g; g/100g; g/100g
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 69379-010-15

5 PACKAGE in 1 BOX (69379-010-15) > 3 PATCH in 1 PACKAGE > 100 g in 1 PATCH
Marketing Start Date2015-03-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69379-010-15 [69379001015]

Permavan External Patch PATCH
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-03-09
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TROLAMINE SALICYLATE10 g/100g

OpenFDA Data

SPL SET ID:10dfa403-1c19-6374-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1605107
  • UPC Code
  • 0569379010152
  • Pharmacological Class

    • Amide Local Anesthetic [EPC]
    • Amides [CS]
    • Antiarrhythmic [EPC]
    • Local Anesthesia [PE]
    • Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]
    • Sigma-1 Agonist [EPC]
    • Uncompetitive NMDA Receptor Antagonists [MoA]
    • Sigma-1 Receptor Agonists [MoA]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.